New research reveals that manufacturers could sell generic versions of Novo Nordisk’s blockbuster drugs, Ozempic and Wegovy, for less than $3 a month. This study highlights a massive gap between current list prices and actual production costs. It suggests a future where powerful weight-loss treatments are accessible to billions. The Massive Gap In Generic Semaglutide Pricing Researchers at the University…
Category: March 2026
-
FDA Biosimilar Development Guidance Targets Treatment Costs
\n\nBiologic medicines are made from living cells and are among the most expensive therapies available. While they account for only 5% of all prescriptions, they are responsible for a staggering 51% of total drug spending in the United States. To address this imbalance, the FDA is prioritising the expansion of the biosimilar market.\n\n\n\nThe new FDA biosimilar development guidance focuses on…
-
NHI Corruption Risks Heightened By Home Affairs Scandal, Arrests
The integrity of South Africa’s future healthcare system is under intense scrutiny. Recent investigations by the Special Investigating Unit (SIU) have exposed deep-seated rot within the Department of Home Affairs. These findings provide a grim reminder of the systemic challenges facing South African governance. For the healthcare industry, these revelations are particularly troubling, highlighting the risks of NHI corruption. They…
-
NHI Preparations Continue Despite Legal Pause
\n\nThe NHI remains one of the most debated policy projects in South Africa. It currently faces more than twelve separate legal challenges. Recent court developments have focused on the legality of the process rather than the NHI model itself.\n\n\n\nNHI Preparations are Ongoing Despite Agreement on Act\n\n\n\nLast week, Minister Motsoaledi and President Cyril Ramaphosa reached an agreement regarding the Act. They…
-
AfroCentric Results Show Revenue Surged Significantly
AfroCentric Investment Corporation has released its financial results for the year ending December. The JSE-listed healthcare giant reported a massive spike in revenue. However, the group also faced a significant basic loss. This was primarily due to heavy asset impairments and strategic business disposals. Massive Revenue Growth For AfroCentric The group’s continuing operations showed exceptional top-line growth. Total revenue climbed…
-
Huawei AI In Healthcare Drives Global Clinical Innovation
Chinese technology giant Huawei is intensifying its investment in Huawei AI in Healthcare, positioning its new tools as “transformative” solutions for the sector. The company, already a major player in South Africa’s energy and banking industries, has identified healthcare as a priority area for growth and service modernisation. In its domestic market, the “AI+ healthcare” initiative is applying artificial intelligence…
-
Discovery Vitality Results Show Surge In Global Profitability
Discovery has reported a significant boost in its latest financial period. The group’s strategy to unify its Vitality composite onto a single platform is yielding impressive returns. These Discovery Vitality results highlight a 41% increase in normalised profit for the composite. This figure reached R2.1 billion for the six months ending December. In a strategic move during 2024, the Discovery…
-
Aspen Pharmacare Debt-Free: Strategic Shift To GLP-1 Injectables
Aspen Pharmacare has officially closed the chapter on its leveraged era. For the first time since the company was founded in 1997, CEO Stephen Saad has confirmed the group is debt-free. This significant milestone follows the massive sale of its Asia-Pacific operations (excluding China) to BGH Capital. The deal, concluded at the end of last year, was valued at A$2.37…
-
Global Fund Fraud Case: Health Director-General Arrested
The National Department of Health (NDoH) has plunged into a fresh governance crisis. The Hawks arrested Director-General Sandile Buthelezi and two senior colleagues this week. They face serious fraud and theft charges linked to the Global Fund for HIV/AIDS, Malaria & TB. The Hawks arrested the suspects for allegedly misusing Global Fund resources. While the international fund supports critical health…